Application
PKD2L1 Antibody (N-term) western blot analysis in CEM cell line lysates (35ug/lane).This demonstrates the PKD2L1 antibody detected the PKD2L1 protein (arrow).| Product Name | PKD2L1 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | PKD2L1; PKD2L; PKDL; Polycystic kidney disease 2-like 1 protein; Polycystin-2 homolog; Polycystin-2L1; Polycystin-L; Polycystin-L1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | PKD2L PKDL |
|---|---|
| Alternative Names | PKD2L1 PKD2L PKDL Polycystic kidney disease 2-like 1 protein Polycystin-2 homolog Polycystin-2L1 Polycystin-L Polycystin-L1 |
| Molecular Weight(MW) | 91982 Da |
| Function | May function as a subunit of an ion channel and act as a transducer of calcium-mediated signaling |
| Tissue Specificity | Expressed in adult heart, skeletal muscle, brain, spleen, testis, retina and liver. According to PubMed:9748274, expressed at high levels in fetal tissues, including kidney and liver, and down-regulated in adult tissues According to PubMed:10602361, expressed in fetal brain, but not expressed in fetal lung, liver or kidney. Isoform 4 appears to be expressed only in transformed lymphoblasts |
| Cellular Localization | Membrane; Multi-pass membrane protein (Potential) |
| Entrez Gene | 9033 |
|---|---|
| Nucleotide Accession | NP_057196.2 |
Application
PKD2L1 Antibody (N-term) western blot analysis in CEM cell line lysates (35ug/lane).This demonstrates the PKD2L1 antibody detected the PKD2L1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
